Lilly-Fluoxetine 20 20 mg Capsules

Lilly-Fluoxetine 20 20 mg Capsules

S5
PDF Leaflet Revision Date: 17 January 2022

API: Fluoxetine | Company: Eli Lilly (SA)

Clinical Summary

Quick overview from the medicine insert

Indication

Major depressive episodes, bulimia nervosa, obsessive-compulsive disorder.

Dosage (summary)

20 mg/day for adults/elderly, 60 mg/day for bulimia, 20-60 mg/day for OCD.

Special Populations

  • Elderly
  • Hepatic impairment
  • Renal impairment

Pregnancy & Breastfeeding

Use in pregnancy only if benefits outweigh risks; excreted in breast milk.

Key Drug Interactions

  • CYP2D6 inhibitors
  • Monoamine oxidase inhibitors
  • Tamoxifen

Contraindications

  • Hypersensitivity
  • Severe renal failure
  • Concomitant use with MAOIs

Common side effects

  • Headache
  • Nausea
  • Insomnia
  • Fatigue
  • Diarrhoea

Counselling Points

  • Monitor for worsening depression
  • Avoid alcohol
  • Report any distressing thoughts

Serious warnings

  • Suicidal thoughts
  • Serotonin syndrome
  • QT prolongation

Only Available on the App

To ensure the fastest, most secure experience, this feature is exclusively available on the free Medinsert mobile app.

Download the App. Its Free!
On This Page
Lilly-Fluoxetine 20 20 mg Capsules
1/-
Loading package insert…

Medinsert AI

Hello! I am Medinsert Ai. What would you like to know about this professional information leaftleft?
App Icon

Medinsert Mobile App

3000+ Package Inserts on the go.

VIEW